297 related articles for article (PubMed ID: 17041717)
21. Hematopoietic stem cell gene transfer for the treatment of hemoglobin disorders.
Persons DA
Hematology Am Soc Hematol Educ Program; 2009; ():690-7. PubMed ID: 20008255
[TBL] [Abstract][Full Text] [Related]
22. Hemoglobin gene therapy for β-thalassemia.
Bank A
Hematol Oncol Clin North Am; 2010 Dec; 24(6):1187-201. PubMed ID: 21075288
[TBL] [Abstract][Full Text] [Related]
23. Fetal globin induction--can it cure beta thalassemia?
Perrine SP
Hematology Am Soc Hematol Educ Program; 2005; ():38-44. PubMed ID: 16304357
[TBL] [Abstract][Full Text] [Related]
24. [Clinico-biological and immunohaematological profile of patients with β-thalassemia in Tunisia: about 26 cases].
Romdhane H; Amara H; Abdelkefi S; Souyeh N; Chakroun T; Jarrey I; Bouslama M; Belhedi S; Houissa B; Boughammoura L; Jemni Yacoub S
Transfus Clin Biol; 2014 Dec; 21(6):309-13. PubMed ID: 25458984
[TBL] [Abstract][Full Text] [Related]
25. Beta-thalassemia and sickle cell disease in culture of early erythroid precursors: hemoglobin synthesis and ultrastructural study.
Beuzard Y; Tulliez M; Testa U; Vainchenker W; Dubart A; Tsapis A; Galacteros F; Breton-Gorius J; Rosa J
Blood Cells; 1981; 7(1):179-200. PubMed ID: 7187747
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and genetic analysis of α-thalassemia and β-thalassemia in Chongqing area of China.
Yao XY; Yu J; Chen SP; Xiao JW; Zheng QC; Liu HY; Zhang L; Xian Y; Zou L
Gene; 2013 Dec; 532(1):120-4. PubMed ID: 24055728
[TBL] [Abstract][Full Text] [Related]
27. Beta-thalassemia.
Galanello R; Origa R
Orphanet J Rare Dis; 2010 May; 5():11. PubMed ID: 20492708
[TBL] [Abstract][Full Text] [Related]
28. Recent advances in globin gene transfer for the treatment of beta-thalassemia and sickle cell anemia.
Sadelain M
Curr Opin Hematol; 2006 May; 13(3):142-8. PubMed ID: 16567956
[TBL] [Abstract][Full Text] [Related]
29. β-Thalassemia.
Origa R
Genet Med; 2017 Jun; 19(6):609-619. PubMed ID: 27811859
[TBL] [Abstract][Full Text] [Related]
30. β-Thalassemia: evolving treatment options beyond transfusion and iron chelation.
Langer AL; Esrick EB
Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):600-606. PubMed ID: 34889443
[TBL] [Abstract][Full Text] [Related]
31. [Umbilical cord blood transplantation for patients with beta-thalassemia major].
Sun X; Liu S; Hao WG; Chen ZX; Guo NL
Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):178-82. PubMed ID: 15833187
[TBL] [Abstract][Full Text] [Related]
32. Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload.
Daar S; Pathare AV
Ann Hematol; 2006 May; 85(5):315-9. PubMed ID: 16450126
[TBL] [Abstract][Full Text] [Related]
33. Current status of beta-thalassemia and its treatment strategies.
Ali S; Mumtaz S; Shakir HA; Khan M; Tahir HM; Mumtaz S; Mughal TA; Hassan A; Kazmi SAR; Sadia ; Irfan M; Khan MA
Mol Genet Genomic Med; 2021 Dec; 9(12):e1788. PubMed ID: 34738740
[TBL] [Abstract][Full Text] [Related]
34. Parallel assessment of globin lentiviral transfer in induced pluripotent stem cells and adult hematopoietic stem cells derived from the same transplanted β-thalassemia patient.
Tubsuwan A; Abed S; Deichmann A; Kardel MD; Bartholomä C; Cheung A; Negre O; Kadri Z; Fucharoen S; von Kalle C; Payen E; Chrétien S; Schmidt M; Eaves CJ; Leboulch P; Maouche-Chrétien L
Stem Cells; 2013 Sep; 31(9):1785-94. PubMed ID: 23712774
[TBL] [Abstract][Full Text] [Related]
35. Transgenic human alpha-hemoglobin stabilizing protein could partially relieve betaIVS-2-654-thalassemia syndrome in model mice.
Wang B; Fang Y; Guo X; Ren Z; Zhang J
Hum Gene Ther; 2010 Feb; 21(2):149-56. PubMed ID: 20063986
[TBL] [Abstract][Full Text] [Related]
36. Beta Thalassemia: Monitoring and New Treatment Approaches.
Khandros E; Kwiatkowski JL
Hematol Oncol Clin North Am; 2019 Jun; 33(3):339-353. PubMed ID: 31030806
[TBL] [Abstract][Full Text] [Related]
37. Response to hydroxyurea treatment in Iranian transfusion-dependent beta-thalassemia patients.
Yavarian M; Karimi M; Bakker E; Harteveld CL; Giordano PC
Haematologica; 2004 Oct; 89(10):1172-8. PubMed ID: 15477200
[TBL] [Abstract][Full Text] [Related]
38. Immune Status 'in Children with Beta Thalassemia' in Correlation 'with Iron Overload': Single Center Egyptian Study.
Hagag AA; Elgamsy MA; El-Asy HM; Gamal RM; Elshahaby WN; Abd Elbar ES
Endocr Metab Immune Disord Drug Targets; 2016; 16(3):181-188. PubMed ID: 27829333
[TBL] [Abstract][Full Text] [Related]
39. Lentiviral globin gene therapy with reduced-intensity conditioning in adults with β-thalassemia: a phase 1 trial.
Boulad F; Maggio A; Wang X; Moi P; Acuto S; Kogel F; Takpradit C; Prockop S; Mansilla-Soto J; Cabriolu A; Odak A; Qu J; Thummar K; Du F; Shen L; Raso S; Barone R; Di Maggio R; Pitrolo L; Giambona A; Mingoia M; Everett JK; Hokama P; Roche AM; Cantu VA; Adhikari H; Reddy S; Bouhassira E; Mohandas N; Bushman FD; Rivière I; Sadelain M
Nat Med; 2022 Jan; 28(1):63-70. PubMed ID: 34980909
[TBL] [Abstract][Full Text] [Related]
40. Gene Addition Strategies for β-Thalassemia and Sickle Cell Anemia.
Dong AC; Rivella S
Adv Exp Med Biol; 2017; 1013():155-176. PubMed ID: 29127680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
